AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Glibenclamide in South Africa
9 products registered with SAHPRA — 8 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| MELIX | T/21.2/174 | Pharmacare Limited û Woodmead | suspended | 29 Jul 2024 |
| GLUCOVANCE 500 mg/2,5 mg | 36/21.2/0412 | Merck (Pty) Ltd | active | 1 Jan 1900 |
| GLIBENCLAMIDE 5 OETHMAAN | T/21.2/150 | Oethmaan Biosims (Pty) Ltd | active | 1 Jan 1900 |
| GLYCOMIN | Q/21.2/24 | Adcock Ingram Limited | active | 1 Jan 1900 |
| BIO GLIBENCLAMIDE 5 | V/21.2/345 | Biotech Laboratories (Pty) Ltd | active | 1 Jan 1900 |
| GLYCOMIN - 3,5 | W/21.2/359 | Adcock Ingram Limited | active | 1 Jan 1900 |
| DIACARE | 32/21.2/0407 | Unimed Healthcare (Pty) Ltd | active | 1 Jan 1900 |
| GLUCOVANCE 500 mg/5 mg | 36/21.2/0413 | Merck (Pty) Ltd | active | 1 Jan 1900 |
| GLYCOMIN - 2,5 | Z/21.2/66 | Pharmacare Limited û Woodmead | active | 1 Jan 1900 |
Glibenclamide — SAHPRA Registration Details
SAHPRA (South Africa) has 9 registered products containing Glibenclamide, of which 8 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Glibenclamide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.